Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
11/12/200911:25MarketwiredWall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key PlayersNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/12/200914:31Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/12/200914:15Business WireAllos Therapeutics’ FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Ly...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200918:22Dow Jones News2nd UPDATE: Celgene To Buy Gloucester Pharma for At Least $340 MillionNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200915:00Business WireAllos Therapeutics’ FOLOTYN™ Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Tre...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200913:41Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/12/200915:00Business WireAllos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN™ at 51st ASH Annual MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/12/200913:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/12/200913:00Business WireAllos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN™ (pralatrexate injection)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200920:04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200913:00Business WireAllos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200921:07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200913:00Business WireAllos Therapeutics Announces Issuance of U.S. Patent for FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/11/200911:38MarketwiredRidgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn EnNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200913:00Business WireAllos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200911:54MarketwiredAnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOPNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200914:51Business WireAllos Therapeutics to Present at Upcoming Conferences in NovemberNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200921:11Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200921:01Business WireAllos Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/11/200910:12MarketwiredGlobal Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.comNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/10/200912:00Business WireAllos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/10/200911:57MarketwiredBenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNKNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200921:23Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200921:05Business WireAllos Therapeutics Announces Closing of Public OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200911:40MarketwiredELNK, HERO, ABAT, NTAP, DBRN and ALTH Receives Analytical Coverage from WallStSense.comNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200922:08Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200911:19Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200911:14Business WireAllos Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/10/200921:08Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/10/200921:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH